Cargando…

L-Glutamine and Survival of Patients with Locally Advanced Head and Neck Cancer Receiving Chemoradiotherapy

We previously reported that L-glutamine reduces the severity of mucositis caused by chemoradiotherapy in patients with head and neck cancer. However, the impact of glutamine on the anti-tumor effect of chemoradiotherapy remains controversial. This study, which included 40 patients, investigated whet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsujimoto, Takae, Wasa, Masafumi, Inohara, Hidenori, Ito, Toshinori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10574413/ https://www.ncbi.nlm.nih.gov/pubmed/37836400 http://dx.doi.org/10.3390/nu15194117

Ejemplares similares

L-glutamine decreases the severity of mucositis induced by chemoradiotherapy in patients with locally advanced head and neck cancer: A double-blind, randomized, placebo-controlled trial
por: TSUJIMOTO, TAKAE, et al.
Publicado: (2015)

Volumetric PET/CT parameters predict local response of head and neck squamous cell carcinoma to chemoradiotherapy
por: Hanamoto, Atsushi, et al.
Publicado: (2014)

Combined Nimotuzumab with Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
por: Thai Hoa, Nguyen Thi, et al.
Publicado: (2020)

Treatment Outcomes of Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy
por: Chen, Yen-Hao, et al.
Publicado: (2017)

Leukocytosis, prognosis biomarker in locally advanced head and neck cancer patients after chemoradiotherapy
por: Schernberg, Antoine, et al.
Publicado: (2018)

Chemoradiotherapy for locally advanced head and neck cancer: 10-year follow-up of the UK Head and Neck (UKHAN1) trial
por: Tobias, Jeffrey S, et al.
Publicado: (2009)

Clinical Impact of Cachexia in Head and Neck Cancer Patients Who Received Chemoradiotherapy
por: Hayashi, Naomi, et al.
Publicado: (2021)

Efficacy of Different Chemotherapy Regimens in Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy
por: Chen, Yen-Hao, et al.
Publicado: (2020)

Chemoradiotherapy for Head and Neck Cancer
por: D’Onofrio, Ida, et al.
Publicado: (2023)

A pharmacist-led opioid de-escalation program after completion of chemoradiotherapy in locally advanced head and neck cancer
por: Horinouchi, Ai, et al.
Publicado: (2023)

Induction chemotherapy with concurrent chemoradiotherapy versus concurrent chemoradiotherapy for locally advanced squamous cell carcinoma of head and neck: a meta-analysis
por: Zhang, Lijuan, et al.
Publicado: (2015)

Cisplatin-Based Chemotherapy versus Cetuximab in Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Cancer Treatment
por: Hu, Ming-Hung, et al.
Publicado: (2014)

Concurrent chemoradiotherapy using gemcitabine and nedaplatin in recurrent or locally advanced head and neck squamous cell carcinoma
por: Huo, Rui-Xue, et al.
Publicado: (2022)

Influence of oral glutamine supplementation on survival outcomes of patients treated with concurrent chemoradiotherapy for locally advanced non-small cell lung cancer
por: Topkan, Erkan, et al.
Publicado: (2012)

Early Loss of Fat Mass During Chemoradiotherapy Predicts Overall Survival in Locally Advanced Squamous Cell Carcinoma of the Lung, but Not in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
por: Willemsen, A. C. H., et al.
Publicado: (2020)

Evaluation of HPV16 E7 expression in head and neck carcinoma cell lines and clinical specimens
por: Kitamura, Koji, et al.
Publicado: (2020)

Transaminase Activity Predicts Survival in Patients with Head and Neck Cancer
por: Takenaka, Yukinori, et al.
Publicado: (2016)

Sarcopenia in male patients with head and neck cancer receiving chemoradiotherapy: a longitudinal pilot study
por: Chauhan, Namrata S., et al.
Publicado: (2020)

Feasibility and Efficacy of Inspiratory Muscle Training in Patients with Head and Neck Cancer Receiving Concurrent Chemoradiotherapy
por: Vira, Prina, et al.
Publicado: (2021)

Evaluation of the Safety of Percutaneous Sensory Nerve Stimulation in Patients with Head and Neck Cancer Receiving Chemoradiotherapy
por: Hamamoto, Takao, et al.
Publicado: (2023)

The Impact of Clinical Prognosis of Viral Hepatitis in Head and Neck Cancer Patients Receiving Concurrent Chemoradiotherapy
por: Wang, Yu-Ming, et al.
Publicado: (2023)

Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients
por: Descamps, Géraldine, et al.
Publicado: (2016)

Induction chemotherapy with paclitaxel, ifosfamide, and cisplatin followed by concurrent chemoradiotherapy for unresectable locally advanced head and neck cancer
por: Chitapanarux, I, et al.
Publicado: (2010)

Modified Weekly Cisplatin-Based Chemotherapy Is Acceptable in Postoperative Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Cancer
por: Lu, Hsueh-Ju, et al.
Publicado: (2015)

Author Correction: Evaluation of HPV16 E7 expression in head and neck carcinoma cell lines and clinical specimens
por: Kitamura, Koji, et al.
Publicado: (2021)

Small Cell Carcinoma of the Larynx Treated by Concurrent Chemoradiotherapy: A Case Report
por: Nakahara, Susumu, et al.
Publicado: (2012)

Effect of exercise training on functional capacity & quality of life in head & neck cancer patients receiving chemoradiotherapy
por: Samuel, Stephen R., et al.
Publicado: (2013)

Genetic Factors Associated with a Poor Outcome in Head and Neck Cancer Patients Receiving Definitive Chemoradiotherapy
por: Vossen, David M., et al.
Publicado: (2019)

Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck
por: Kim, J G, et al.
Publicado: (2005)

Randomized phase III trial of concurrent chemoradiotherapy vs accelerated hyperfractionation radiotherapy in locally advanced head and neck cancer
por: Chitapanarux, Imjai, et al.
Publicado: (2013)

Phase II trial of chemoradiotherapy with S-1 plus cisplatin for unresectable locally advanced head and neck cancer (JCOG0706)
por: Tahara, Makoto, et al.
Publicado: (2015)

Comparison of Carboplatin With 5-Fluorouracil vs. Cisplatin as Concomitant Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
por: Hanemaaijer, Saskia H., et al.
Publicado: (2020)

Dual time point imaging in locally advanced head and neck cancer to assess residual nodal disease after chemoradiotherapy
por: Soffers, Frederik, et al.
Publicado: (2022)

Prognostic impact of sarcopenia in patients with head and neck cancer treated with surgery or radiation: A meta-analysis
por: Takenaka, Yukinori, et al.
Publicado: (2021)

The impact of sarcopenia on survival and treatment tolerance in patients with head and neck cancer treated with chemoradiotherapy
por: Bentahila, Rita, et al.
Publicado: (2022)

Blockade of glutamine-dependent cell survival augments antitumor efficacy of CPI-613 in head and neck cancer
por: Lang, Liwei, et al.
Publicado: (2021)

Respiratory Muscle Function and Exercise Capacity in a Stage 4 Head and Neck Cancer Patient Receiving Chemoradiotherapy
por: D’Souza, Macrina, et al.
Publicado: (2020)

Utility of Prophylactic Percutaneous Gastrostomy in Patients With Head and Neck Cancer Receiving Concurrent Chemoradiotherapy: A Multicenter Analysis
por: Neves, Maria Teresa, et al.
Publicado: (2023)

Chemoradiotherapy With Generic Cisplatin Formulations for Head and Neck Cancers
por: Shimada, Rie, et al.
Publicado: (2018)

The evaluation of the oxidative stress for patients receiving neoadjuvant chemoradiotherapy for locally advanced rectal cancer
por: Serbanescu, GL, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vo35nkg5d1rb4p4s8fnoof1v59